J&J wins FDA approval for dual-energy ablation catheter
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
In this week’s special edition of “News You Can Use” on Healthcare NOW Radio Dr. Nick sits down with Joe Sardano, Founder, Chairman, and CEO of Sensus Healthcare, to explore Sensus and the technology they are bringing to the treatment of skin cancer. The post Skin Cancer Alternat…
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.
In honor of Memorial Day and our living vets, take time this day to remember and honor our service men and women. Check out and follow some of these hashtags throughout the year. Thanks for your service from everyone at Answers Media Network. The post Memorial Day 2026 appeared f…
Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.
With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.
The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.
CMS has released the 2026 CMS Interoperability Standards and Prior Authorization for Drugs proposed rule (CMS-0062-P), continuing its efforts to improve electronic prior authorization so patients and providers can benefit from a more expeditious, transparent and reliable process.…